Skip to main content
. 2014 Jan 9;110(5):1148–1154. doi: 10.1038/bjc.2013.813

Table 2. Details of prior therapy (Phase II patients).

  Patients, N=54 %
Type of prior therapy
Surgery for primary tumour 47 87.0
Surgery for metastases 17 31.5
Adjuvant chemotherapy 24 44.4
Palliative chemotherapy 54 100.0
 1 Line 7 12.9
 2 Lines 11 20.4
 3 Lines 15 27.8
 ⩾ 4 Lines 21 38.9
Radiotherapy
25
46.3
Failure of previous medication
5-FU 54 100.0
Irinotecan 54 100.0
Oxaliplatin 52 96.3
Bevacizumab 49 90.7
Cetuximab 9 16.7